TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP. Share Price

Certificat

DE000SB077Y6

Real-time Boerse Frankfurt Warrants 08:27:35 13/05/2024 BST
13.96 EUR -1.69% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - STRYKER CORP.
Current month-5.02%
1 month-10.92%
Date Price Change Volume
13/05/24 13.96 -1.69% 0
10/05/24 14.2 0.00% 0
09/05/24 14.2 +1.65% 0
08/05/24 13.97 -1.69% 0
07/05/24 14.21 +3.80% 0

Real-time Boerse Frankfurt Warrants

Last update May 13, 2024 at 08:27 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SB077Y
ISINDE000SB077Y6
Date issued 09/06/2020
Strike 178.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 5.87
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 16.93
Lowest since issue 2.91
Spread 0.5
Spread %3.46%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus